This article on Epainassist.com has been reviewed by a medical professional, as well as checked for facts, to assure the readers the best possible accuracy.

We follow a strict editorial policy and we have a zero-tolerance policy regarding any level of plagiarism. Our articles are resourced from reputable online pages. This article may contains scientific references. The numbers in the parentheses (1, 2, 3) are clickable links to peer-reviewed scientific papers.

The feedback link “Was this Article Helpful” on this page can be used to report content that is not accurate, up-to-date or questionable in any manner.

This article does not provide medical advice.


What Is The Prognosis For Olfactory Neuroblastoma & Lifestyle Changes For It?

Olfactory neuroblastomas, also known as esthesioneuroblastomas is a multi-omics examination of the atypical nasal tumor developing in the olfactory epithelium in the upper cavity of the nose. It generally makes a nasal block and secondary sinus infection and is often misunderstood by the doctor for a nasal polyp.

The best possible therapy for all patients with olfactory neuroblastomas (ONB) is maximum surgical exclusion pursued by radiation and in some cases chemotherapy. By integrating cutting edge technology and instrumentation with recognized surgical experience, we make surgical treatment for ONBs and related skull base polyps safer, less invasive and more successful.

What Is The Prognosis For Olfactory Neuroblastoma?

Olfactory neuroblastoma has been noticed to cause mortality by distant metastasis or by invasion via the cribriform plate and consequent meningitis in nearly all cases and is commonly related with a minimal remedy ratio. This ground-breaking, nominally invasive procedure uses the nose and nasal cavities as biological passages to open hard-to-reach or formerly untreatable cancers.

A study was conducted to analyze the clinical characteristics, its enduring treatment results and prognostic aspects in association with 20 + cases of olfactory neuroblastomas. These patients were treated from Jan 1978 to October 2000.

The NBS patients were monitored in 28.5 months and the extent of the tumor was determined during every staging system. The classification was based upon the UCLA staging system, and according to this system, there were 3 cases of T1, 5 of T2, 6 of T3, and 7 of T4.1,2

Among the 20+ cases, only 21 percent of people survived the 5-year survival period with an average survival month of 28 months. However, the group which underwent radical surgical resection was able to survive for extended years and the mortality time was fewer when compared to the previous group of patients. Their survival was much higher than the patients who were treated through radiation and chemotherapy treatment. The relapse time was close to 8 months. Based on these findings, the researchers concluded that tumor identification in the initial period could bring more positive outcomes in comparison to the later identification of cancer.

Multimodal treatment involving radiotherapy with detailed therapy planning based on CT simulation attained an outstanding local control rate with appropriate toxicity and satisfactory overall survival for patients with olfactory neuroblastoma.3

Lifestyle Changes For Olfactory Neuroblastoma

A collection of distinct scanning practices helps analyze the nasal cavity. These include X-rays, CT scans, and MRI. To obtain further data, your physician may carry out a biopsy. The type of biopsy is often dependent on the location of cancer. The biopsy was performed using standard techniques with 22-gauge and 23-gauge needles.

Few neoplasms are unique to the Sinonasal tract, but Sinonasal undifferentiated carcinoma and olfactory neuroblastoma are cancerous growths that necessitate exclusive management. Due to the rarity of these cancers, you should adopt certain lifestyle changes with which you can manage your symptoms and help improve the condition. These instances are often presented for discussion, further indicating the analytical obstacles fundamental to these tumors.

Olfactory neuroblastoma may histologically simulate several forms of cancer within the sinonasal passage, making it more complicated to identify. The management of olfactory neuroblastoma involves cranial-facial clinical methodology, trephination process, which is scientifically difficult and accomplishing decent outcomes is challenging. Olfactory neuroblastoma occurs more frequently in the 3rd and 6th spans of life and appears similarly in each gender.

Following the staging of olfactory neuroblastoma, multidisciplinary methodologies have been employed for therapy, and no universal therapy approach has still been found.4,5


  1. Olfactory neuroblastomas: survival rate and prognostic factor https://www.ncbi.nlm.nih.gov/pubmed/12241118
  2. Olfactory Neuroblastoma – Management and Prognosis https://jamanetwork.com/journals/jamaotolaryngology/article-abstract/605561
  3. Olfactory neuroblastoma. Management and prognosis. https://www.ncbi.nlm.nih.gov/pubmed/804302
  4. Olfactory neuroblastoma: the long-term outcome and late toxicity of multimodal therapy including radiotherapy based on treatment planning using computed tomography https://ro-journal.biomedcentral.com/articles/10.1186/s13014-015-0397-5
  5. Nasal cavity, paranasal sinuses, nasopharynx other tumors http://www.pathologyoutlines.com/topic/nasalolfactoryneuroblastoma.html

Also Read:

Sheetal DeCaria, M.D.
Sheetal DeCaria, M.D.
Written, Edited or Reviewed By: Sheetal DeCaria, M.D. This article does not provide medical advice. See disclaimer
Last Modified On:March 12, 2020

Recent Posts

Related Posts